Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
about
Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.Cell-surface G-protein-coupled receptors for tumor-associated metabolites: A direct link to mitochondrial dysfunction in cancer.Inhibition of Glycolysis and Glutaminolysis: Emerging Drug Discovery Approach to Combat Cancer.
P2860
Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
@en
type
label
Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
@en
prefLabel
Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
@en
P2860
P356
P1433
P1476
Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
@en
P2093
Ellappan Babu
Yangzom D Bhutia
P2860
P304
P356
10.1042/BCJ20160068
P407
P577
2016-06-01T00:00:00Z